Assenagon Asset Management S.A.
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in SRPT
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$8,165,118
+$7,597,000 QoQ
Shares Held
454,375
+1441.2% QoQ
Ownership
0.430%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 19 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. SRPT ranks #32 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in SRPT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,165,118 | 454,375 | Shares | Sole | 2026-07-08 | |
| 2025-09-30 | $568,118 | 29,482 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $14,841,756 | 867,939 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $45,476,919 | 712,581 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $16,105,568 | 132,458 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $43,717,994 | 350,052 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $56,831,968 | 359,696 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $56,663,347 | 437,690 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $37,007,808 | 383,779 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $51,922,526 | 428,333 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $83,117,127 | 725,787 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $83,958,868 | 609,148 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $94,921,496 | 732,532 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $124,801,428 | 1,129,016 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $33,220,098 | 443,171 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $43,045,682 | 551,020 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $19,677,455 | 218,517 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $356,325 | 3,853 | Shares | Sole | 2021-10-19 | |
| 2020-09-30 | $9,351,233 | 66,590 | Shares | Sole | 2020-10-07 | |
| No filing history on record for this holder in this stock. | ||||||